SlideShare ist ein Scribd-Unternehmen logo
1 von 18
Downloaden Sie, um offline zu lesen
Presentation
           by Dr. med. Karl-Peter Klein
            Dip Pharm Med RCP UK, FFPM RCP UK

Managing Director
AtoZ-CRO GmbH
Clinical Research
Leyenhaus 29, 51491 Overath/Germany
e-mail: kp.klein@atoz-cro.de
www.atoz-cro.de

 Presented at the Marcus Evans Evolution Summit
                    Conference
 Westin Chicago North Shore - Wheeling, IL, USA
                  on May 1, 2012




                        2012‐05‐01                1
How can Europe help to speed up
    your drug development

           Conditions,
Rules and Cost of doing clinical
 trials in Central and Eastern
             Europe


                                   2
Content
• Patients with rare diseases
• Availability of motivated patients
• Drug naive patients
• Motivated investigators
• Very experienced investigators
• Quality of data
• Fast Marketing Autorisation
• Fast Marketing Success
• Cost for clinical trials is lower in Europe
• Conditions to start trials in Europe
                                                4
How can Europe help to speed up your drug development


                 Rare Diseases

  Europe can help to speed up recruitment
    by having access to greater patient
       populations in rare diseases




                                                   5
How can Europe help to speed up your drug development

      Availability of motivated patients

  Esp. in Eastern Europe for certain patients
   there is a lack of medical treatment; this
  causes a high motivation to enter clinical
                      trials
  Patients travel long distances to meet the
                  investigators
  Patients are highly motivated and show a
                high compliance
                                                    6
How can Europe help to speed up your drug development

              Drug Naive Patients

    In some areas in Europe patients are not
 overloaded with other drugs as they are in the
US or Germany, this means drug effects may be
  seen clearer and earlier, this is of incredible
value and may speed up development process or
             allow earlier decisions

                                                     7
How can Europe help to speed up your drug development


         Many motivated Investigators

       In Europe there are many highly
      motivated investigators and trial sites




                                                        8
How can Europe help to speed up your drug development


        Very experienced Investigators

         In Europe there are many very
     experienced investigators and trial sites




                                                        9
How can Europe help to speed up your drug development

                Quality of Data

  Most inspection results by the US FDA in
  Europe have shown a good quality of data

 Based on experience of inspectors from the
 US FDA, the number of findings in Europe
      are about the same as in the US
                                                    10
How can Europe help to speed up your drug development

     The cost for clinical trials is lower in
           Europe compared to US

      In Western Europe cost is about 80%
          In Eastern Europe about 50%
              of the cost in the US



                                                    11
How can Europe help to speed up your drug development

         Fast Marketing Autorisation


    Involvement of study sites in Europe in
   early drug development supports the later
           appoval process in Europe




                                                    12
How can Europe help to speed up your drug development

            Fast Marketing Success


    Involvement of study sites in Europe in
    the drug development later on supports
         the marketing of these drugs




                                                    13
Conditions, Rules of doing clinical trials in Europe

      Conditions to start trials in Europe

• There is a certain hormonization in the EU
  countries
• Offices in Europe or a legal representative
• Qualified Person for PV within the EU
• Approval of the Clinical Trial Application by
   the Competent Authority
• Positive vote by the Ethics Committee (EC)
                                                   14
Conditions, Rules of doing clinical trials in
                 Europe

               CTA Review

- Applicaton is validated
- 30 (or 60) days review
- Deficiency letter may be issued
- After the response an additonal
review is completed

                                                15
The ICH-GCP compliance, the
availability of subjects, the quality of
investigators, the time-reduced and the
low costs are by far the important
criteria for choosing Eastern Europe
countries to conduct clinical trials.




                                           16
Conclusion
Conducting trials in Europe may help to

- accelerate development
- reduce costs
- support international registration
- support international marketing


                                       17
Thank you




            18

Weitere ähnliche Inhalte

Ähnlich wie How Can Europe Help to Speed Up Your Drug Development - Karl Peter Klein, AtoZ-CRO GmbH

EUPATI’s framework on Informing the “health-interested” public about medicine...
EUPATI’s framework on Informing the “health-interested” public about medicine...EUPATI’s framework on Informing the “health-interested” public about medicine...
EUPATI’s framework on Informing the “health-interested” public about medicine...Nowgen
 
"Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep To...
"Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep To..."Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep To...
"Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep To...Vall d'Hebron Institute of Research (VHIR)
 
The regulation of medicines in Australia
The regulation of medicines in AustraliaThe regulation of medicines in Australia
The regulation of medicines in AustraliaTGA Australia
 
European Patients’ Academy on Therapeutic Innovation: Shifting paradigms in ...
European Patients’ Academy on Therapeutic Innovation:Shifting paradigms in ...European Patients’ Academy on Therapeutic Innovation:Shifting paradigms in ...
European Patients’ Academy on Therapeutic Innovation: Shifting paradigms in ...patvocates
 
The patient voice: turning health policy into opportunity - Jan Geissler - ES...
The patient voice: turning health policy into opportunity - Jan Geissler - ES...The patient voice: turning health policy into opportunity - Jan Geissler - ES...
The patient voice: turning health policy into opportunity - Jan Geissler - ES...patvocates
 
SMi Group's Orphan Drugs conference
SMi Group's Orphan Drugs conferenceSMi Group's Orphan Drugs conference
SMi Group's Orphan Drugs conferenceDale Butler
 
European Patients' Academy - Presentation at IMI Patient Focus Meeting on 12 ...
European Patients' Academy - Presentation at IMI Patient Focus Meeting on 12 ...European Patients' Academy - Presentation at IMI Patient Focus Meeting on 12 ...
European Patients' Academy - Presentation at IMI Patient Focus Meeting on 12 ...EUPATI
 
Future Health Summit - Dr Derick Mitchell - May 26th 2016
Future Health Summit - Dr Derick Mitchell - May 26th 2016Future Health Summit - Dr Derick Mitchell - May 26th 2016
Future Health Summit - Dr Derick Mitchell - May 26th 2016ipposi
 
Derick mitchell, IPPOSI
Derick mitchell, IPPOSIDerick mitchell, IPPOSI
Derick mitchell, IPPOSIInvestnet
 
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...EUPATI
 
What do people think about medicines research and development? (Starling, EUP...
What do people think about medicines research and development? (Starling, EUP...What do people think about medicines research and development? (Starling, EUP...
What do people think about medicines research and development? (Starling, EUP...Nowgen
 
ENCA 2016 - Genoa - Bas Vastert
ENCA 2016 - Genoa - Bas VastertENCA 2016 - Genoa - Bas Vastert
ENCA 2016 - Genoa - Bas Vastertanton gruss
 
SMi Group's 9th annual Paediatric Clinical Trials conference
SMi Group's 9th annual Paediatric Clinical Trials conferenceSMi Group's 9th annual Paediatric Clinical Trials conference
SMi Group's 9th annual Paediatric Clinical Trials conferenceDale Butler
 
Changes in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical worldChanges in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical worldjangeissler
 

Ähnlich wie How Can Europe Help to Speed Up Your Drug Development - Karl Peter Klein, AtoZ-CRO GmbH (20)

EUPATI’s framework on Informing the “health-interested” public about medicine...
EUPATI’s framework on Informing the “health-interested” public about medicine...EUPATI’s framework on Informing the “health-interested” public about medicine...
EUPATI’s framework on Informing the “health-interested” public about medicine...
 
Orphan Drugs
Orphan DrugsOrphan Drugs
Orphan Drugs
 
"Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep To...
"Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep To..."Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep To...
"Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep To...
 
The regulation of medicines in Australia
The regulation of medicines in AustraliaThe regulation of medicines in Australia
The regulation of medicines in Australia
 
European Patients’ Academy on Therapeutic Innovation: Shifting paradigms in ...
European Patients’ Academy on Therapeutic Innovation:Shifting paradigms in ...European Patients’ Academy on Therapeutic Innovation:Shifting paradigms in ...
European Patients’ Academy on Therapeutic Innovation: Shifting paradigms in ...
 
The patient voice: turning health policy into opportunity - Jan Geissler - ES...
The patient voice: turning health policy into opportunity - Jan Geissler - ES...The patient voice: turning health policy into opportunity - Jan Geissler - ES...
The patient voice: turning health policy into opportunity - Jan Geissler - ES...
 
SMi Group's Orphan Drugs conference
SMi Group's Orphan Drugs conferenceSMi Group's Orphan Drugs conference
SMi Group's Orphan Drugs conference
 
European Patients' Academy - Presentation at IMI Patient Focus Meeting on 12 ...
European Patients' Academy - Presentation at IMI Patient Focus Meeting on 12 ...European Patients' Academy - Presentation at IMI Patient Focus Meeting on 12 ...
European Patients' Academy - Presentation at IMI Patient Focus Meeting on 12 ...
 
P 113 geriatric
P 113 geriatricP 113 geriatric
P 113 geriatric
 
Future Health Summit - Dr Derick Mitchell - May 26th 2016
Future Health Summit - Dr Derick Mitchell - May 26th 2016Future Health Summit - Dr Derick Mitchell - May 26th 2016
Future Health Summit - Dr Derick Mitchell - May 26th 2016
 
The current regulatory framework
The current regulatory frameworkThe current regulatory framework
The current regulatory framework
 
Derick mitchell, IPPOSI
Derick mitchell, IPPOSIDerick mitchell, IPPOSI
Derick mitchell, IPPOSI
 
ICH GCP
ICH GCPICH GCP
ICH GCP
 
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
 
What do people think about medicines research and development? (Starling, EUP...
What do people think about medicines research and development? (Starling, EUP...What do people think about medicines research and development? (Starling, EUP...
What do people think about medicines research and development? (Starling, EUP...
 
ODRD 2016
ODRD 2016ODRD 2016
ODRD 2016
 
ENCA 2016 - Genoa - Bas Vastert
ENCA 2016 - Genoa - Bas VastertENCA 2016 - Genoa - Bas Vastert
ENCA 2016 - Genoa - Bas Vastert
 
SMi Group's 9th annual Paediatric Clinical Trials conference
SMi Group's 9th annual Paediatric Clinical Trials conferenceSMi Group's 9th annual Paediatric Clinical Trials conference
SMi Group's 9th annual Paediatric Clinical Trials conference
 
Owen Vaughan prometics crdn summit 2017
Owen Vaughan prometics crdn summit 2017Owen Vaughan prometics crdn summit 2017
Owen Vaughan prometics crdn summit 2017
 
Changes in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical worldChanges in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical world
 

Mehr von Life Sciences Network marcus evans

The Power of Digital Measures in Clinical Trials - Erwin De beuckelaer, Jans...
The Power of Digital Measures in Clinical Trials  - Erwin De beuckelaer, Jans...The Power of Digital Measures in Clinical Trials  - Erwin De beuckelaer, Jans...
The Power of Digital Measures in Clinical Trials - Erwin De beuckelaer, Jans...Life Sciences Network marcus evans
 
Optimizing Clinical Trial Operations - Alexander Fetkovsky, SanaClis
Optimizing Clinical Trial Operations - Alexander Fetkovsky, SanaClisOptimizing Clinical Trial Operations - Alexander Fetkovsky, SanaClis
Optimizing Clinical Trial Operations - Alexander Fetkovsky, SanaClisLife Sciences Network marcus evans
 
How Sponsors and Vendors Can Form a True Partnership-Kristine Koontz, GSK
How Sponsors and Vendors Can Form a True Partnership-Kristine Koontz, GSKHow Sponsors and Vendors Can Form a True Partnership-Kristine Koontz, GSK
How Sponsors and Vendors Can Form a True Partnership-Kristine Koontz, GSKLife Sciences Network marcus evans
 
Technological Crossroads: Navigating the Intersection between Recruitment, Re...
Technological Crossroads: Navigating the Intersection between Recruitment, Re...Technological Crossroads: Navigating the Intersection between Recruitment, Re...
Technological Crossroads: Navigating the Intersection between Recruitment, Re...Life Sciences Network marcus evans
 
Beyond the Hype: Practical Approaches for Implementing Machine Learning and A...
Beyond the Hype: Practical Approaches for Implementing Machine Learning and A...Beyond the Hype: Practical Approaches for Implementing Machine Learning and A...
Beyond the Hype: Practical Approaches for Implementing Machine Learning and A...Life Sciences Network marcus evans
 
Keeping up with ICH E6(R2): Risk-Based Monitoring (RBM) Redefined
Keeping up with ICH E6(R2): Risk-Based Monitoring (RBM) RedefinedKeeping up with ICH E6(R2): Risk-Based Monitoring (RBM) Redefined
Keeping up with ICH E6(R2): Risk-Based Monitoring (RBM) RedefinedLife Sciences Network marcus evans
 
Turning Sponsor/CRO Relationships into Partnerships for Success
Turning Sponsor/CRO Relationships into Partnerships for SuccessTurning Sponsor/CRO Relationships into Partnerships for Success
Turning Sponsor/CRO Relationships into Partnerships for SuccessLife Sciences Network marcus evans
 
Evolving Risk-Based Monitoring to Improve Clinical Studies-Dunya Botetzayas, ...
Evolving Risk-Based Monitoring to Improve Clinical Studies-Dunya Botetzayas, ...Evolving Risk-Based Monitoring to Improve Clinical Studies-Dunya Botetzayas, ...
Evolving Risk-Based Monitoring to Improve Clinical Studies-Dunya Botetzayas, ...Life Sciences Network marcus evans
 
Discovering Key Regulatory Reforms to Enable Accelerated Drug Development and...
Discovering Key Regulatory Reforms to Enable Accelerated Drug Development and...Discovering Key Regulatory Reforms to Enable Accelerated Drug Development and...
Discovering Key Regulatory Reforms to Enable Accelerated Drug Development and...Life Sciences Network marcus evans
 
The Patient’s Perspective: Finding a Cure to Rare Genetic Diseases - Dr Nicol...
The Patient’s Perspective: Finding a Cure to Rare Genetic Diseases - Dr Nicol...The Patient’s Perspective: Finding a Cure to Rare Genetic Diseases - Dr Nicol...
The Patient’s Perspective: Finding a Cure to Rare Genetic Diseases - Dr Nicol...Life Sciences Network marcus evans
 
Targeting Ras and MDS: Rigosertib Taking Aim at Important Targets-Steven Fruc...
Targeting Ras and MDS: Rigosertib Taking Aim at Important Targets-Steven Fruc...Targeting Ras and MDS: Rigosertib Taking Aim at Important Targets-Steven Fruc...
Targeting Ras and MDS: Rigosertib Taking Aim at Important Targets-Steven Fruc...Life Sciences Network marcus evans
 
Individualizing Patient Care through Precision Medicine: Shaping the Industry...
Individualizing Patient Care through Precision Medicine: Shaping the Industry...Individualizing Patient Care through Precision Medicine: Shaping the Industry...
Individualizing Patient Care through Precision Medicine: Shaping the Industry...Life Sciences Network marcus evans
 
Collaboration between Industry and Academia – An Opportunity to Drive Efficie...
Collaboration between Industry and Academia – An Opportunity to Drive Efficie...Collaboration between Industry and Academia – An Opportunity to Drive Efficie...
Collaboration between Industry and Academia – An Opportunity to Drive Efficie...Life Sciences Network marcus evans
 
Considering the End before the Beginning: Choosing the Correct Endpoints - An...
Considering the End before the Beginning: Choosing the Correct Endpoints - An...Considering the End before the Beginning: Choosing the Correct Endpoints - An...
Considering the End before the Beginning: Choosing the Correct Endpoints - An...Life Sciences Network marcus evans
 
Pushing the Innovation Envelope: Strategies for Boosting Productivity and ROI...
Pushing the Innovation Envelope: Strategies for Boosting Productivity and ROI...Pushing the Innovation Envelope: Strategies for Boosting Productivity and ROI...
Pushing the Innovation Envelope: Strategies for Boosting Productivity and ROI...Life Sciences Network marcus evans
 
Biomarkers to Diagnostics – The Essential Tool Box for Drug Development - Joh...
Biomarkers to Diagnostics – The Essential Tool Box for Drug Development - Joh...Biomarkers to Diagnostics – The Essential Tool Box for Drug Development - Joh...
Biomarkers to Diagnostics – The Essential Tool Box for Drug Development - Joh...Life Sciences Network marcus evans
 
Strategies for Maximizing Pediatric Studies: Orphan Indications - Deborah Lee...
Strategies for Maximizing Pediatric Studies: Orphan Indications - Deborah Lee...Strategies for Maximizing Pediatric Studies: Orphan Indications - Deborah Lee...
Strategies for Maximizing Pediatric Studies: Orphan Indications - Deborah Lee...Life Sciences Network marcus evans
 
Forming Powerful Partnerships to Drill Down into the Areas of Expertise of Ea...
Forming Powerful Partnerships to Drill Down into the Areas of Expertise of Ea...Forming Powerful Partnerships to Drill Down into the Areas of Expertise of Ea...
Forming Powerful Partnerships to Drill Down into the Areas of Expertise of Ea...Life Sciences Network marcus evans
 

Mehr von Life Sciences Network marcus evans (20)

The Power of Digital Measures in Clinical Trials - Erwin De beuckelaer, Jans...
The Power of Digital Measures in Clinical Trials  - Erwin De beuckelaer, Jans...The Power of Digital Measures in Clinical Trials  - Erwin De beuckelaer, Jans...
The Power of Digital Measures in Clinical Trials - Erwin De beuckelaer, Jans...
 
Optimizing Clinical Trial Operations - Alexander Fetkovsky, SanaClis
Optimizing Clinical Trial Operations - Alexander Fetkovsky, SanaClisOptimizing Clinical Trial Operations - Alexander Fetkovsky, SanaClis
Optimizing Clinical Trial Operations - Alexander Fetkovsky, SanaClis
 
How Sponsors and Vendors Can Form a True Partnership-Kristine Koontz, GSK
How Sponsors and Vendors Can Form a True Partnership-Kristine Koontz, GSKHow Sponsors and Vendors Can Form a True Partnership-Kristine Koontz, GSK
How Sponsors and Vendors Can Form a True Partnership-Kristine Koontz, GSK
 
Technological Crossroads: Navigating the Intersection between Recruitment, Re...
Technological Crossroads: Navigating the Intersection between Recruitment, Re...Technological Crossroads: Navigating the Intersection between Recruitment, Re...
Technological Crossroads: Navigating the Intersection between Recruitment, Re...
 
Beyond the Hype: Practical Approaches for Implementing Machine Learning and A...
Beyond the Hype: Practical Approaches for Implementing Machine Learning and A...Beyond the Hype: Practical Approaches for Implementing Machine Learning and A...
Beyond the Hype: Practical Approaches for Implementing Machine Learning and A...
 
Keeping up with ICH E6(R2): Risk-Based Monitoring (RBM) Redefined
Keeping up with ICH E6(R2): Risk-Based Monitoring (RBM) RedefinedKeeping up with ICH E6(R2): Risk-Based Monitoring (RBM) Redefined
Keeping up with ICH E6(R2): Risk-Based Monitoring (RBM) Redefined
 
Turning Sponsor/CRO Relationships into Partnerships for Success
Turning Sponsor/CRO Relationships into Partnerships for SuccessTurning Sponsor/CRO Relationships into Partnerships for Success
Turning Sponsor/CRO Relationships into Partnerships for Success
 
Evolving Risk-Based Monitoring to Improve Clinical Studies-Dunya Botetzayas, ...
Evolving Risk-Based Monitoring to Improve Clinical Studies-Dunya Botetzayas, ...Evolving Risk-Based Monitoring to Improve Clinical Studies-Dunya Botetzayas, ...
Evolving Risk-Based Monitoring to Improve Clinical Studies-Dunya Botetzayas, ...
 
Discovering Key Regulatory Reforms to Enable Accelerated Drug Development and...
Discovering Key Regulatory Reforms to Enable Accelerated Drug Development and...Discovering Key Regulatory Reforms to Enable Accelerated Drug Development and...
Discovering Key Regulatory Reforms to Enable Accelerated Drug Development and...
 
The Patient’s Perspective: Finding a Cure to Rare Genetic Diseases - Dr Nicol...
The Patient’s Perspective: Finding a Cure to Rare Genetic Diseases - Dr Nicol...The Patient’s Perspective: Finding a Cure to Rare Genetic Diseases - Dr Nicol...
The Patient’s Perspective: Finding a Cure to Rare Genetic Diseases - Dr Nicol...
 
Targeting Ras and MDS: Rigosertib Taking Aim at Important Targets-Steven Fruc...
Targeting Ras and MDS: Rigosertib Taking Aim at Important Targets-Steven Fruc...Targeting Ras and MDS: Rigosertib Taking Aim at Important Targets-Steven Fruc...
Targeting Ras and MDS: Rigosertib Taking Aim at Important Targets-Steven Fruc...
 
Individualizing Patient Care through Precision Medicine: Shaping the Industry...
Individualizing Patient Care through Precision Medicine: Shaping the Industry...Individualizing Patient Care through Precision Medicine: Shaping the Industry...
Individualizing Patient Care through Precision Medicine: Shaping the Industry...
 
Collaboration between Industry and Academia – An Opportunity to Drive Efficie...
Collaboration between Industry and Academia – An Opportunity to Drive Efficie...Collaboration between Industry and Academia – An Opportunity to Drive Efficie...
Collaboration between Industry and Academia – An Opportunity to Drive Efficie...
 
Considering the End before the Beginning: Choosing the Correct Endpoints - An...
Considering the End before the Beginning: Choosing the Correct Endpoints - An...Considering the End before the Beginning: Choosing the Correct Endpoints - An...
Considering the End before the Beginning: Choosing the Correct Endpoints - An...
 
Pushing the Innovation Envelope: Strategies for Boosting Productivity and ROI...
Pushing the Innovation Envelope: Strategies for Boosting Productivity and ROI...Pushing the Innovation Envelope: Strategies for Boosting Productivity and ROI...
Pushing the Innovation Envelope: Strategies for Boosting Productivity and ROI...
 
Biomarkers to Diagnostics – The Essential Tool Box for Drug Development - Joh...
Biomarkers to Diagnostics – The Essential Tool Box for Drug Development - Joh...Biomarkers to Diagnostics – The Essential Tool Box for Drug Development - Joh...
Biomarkers to Diagnostics – The Essential Tool Box for Drug Development - Joh...
 
Business Development Activities Interview - Clinart MENA
Business Development Activities Interview - Clinart MENABusiness Development Activities Interview - Clinart MENA
Business Development Activities Interview - Clinart MENA
 
Strategies for Maximizing Pediatric Studies: Orphan Indications - Deborah Lee...
Strategies for Maximizing Pediatric Studies: Orphan Indications - Deborah Lee...Strategies for Maximizing Pediatric Studies: Orphan Indications - Deborah Lee...
Strategies for Maximizing Pediatric Studies: Orphan Indications - Deborah Lee...
 
Where marcus evans fits in our business development mix
Where marcus evans fits in our business development mixWhere marcus evans fits in our business development mix
Where marcus evans fits in our business development mix
 
Forming Powerful Partnerships to Drill Down into the Areas of Expertise of Ea...
Forming Powerful Partnerships to Drill Down into the Areas of Expertise of Ea...Forming Powerful Partnerships to Drill Down into the Areas of Expertise of Ea...
Forming Powerful Partnerships to Drill Down into the Areas of Expertise of Ea...
 

Kürzlich hochgeladen

Escorts in Nungambakkam Phone 8250092165 Enjoy 24/7 Escort Service Enjoy Your...
Escorts in Nungambakkam Phone 8250092165 Enjoy 24/7 Escort Service Enjoy Your...Escorts in Nungambakkam Phone 8250092165 Enjoy 24/7 Escort Service Enjoy Your...
Escorts in Nungambakkam Phone 8250092165 Enjoy 24/7 Escort Service Enjoy Your...meghakumariji156
 
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan CytotecJual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan CytotecZurliaSoop
 
UAE Bur Dubai Call Girls ☏ 0564401582 Call Girl in Bur Dubai
UAE Bur Dubai Call Girls ☏ 0564401582 Call Girl in Bur DubaiUAE Bur Dubai Call Girls ☏ 0564401582 Call Girl in Bur Dubai
UAE Bur Dubai Call Girls ☏ 0564401582 Call Girl in Bur Dubaijaehdlyzca
 
Lucknow Housewife Escorts by Sexy Bhabhi Service 8250092165
Lucknow Housewife Escorts  by Sexy Bhabhi Service 8250092165Lucknow Housewife Escorts  by Sexy Bhabhi Service 8250092165
Lucknow Housewife Escorts by Sexy Bhabhi Service 8250092165meghakumariji156
 
PHX May 2024 Corporate Presentation Final
PHX May 2024 Corporate Presentation FinalPHX May 2024 Corporate Presentation Final
PHX May 2024 Corporate Presentation FinalPanhandleOilandGas
 
Berhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Berhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDINGBerhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Berhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDINGpr788182
 
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDINGParadip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDINGpr788182
 
Arti Languages Pre Seed Teaser Deck 2024.pdf
Arti Languages Pre Seed Teaser Deck 2024.pdfArti Languages Pre Seed Teaser Deck 2024.pdf
Arti Languages Pre Seed Teaser Deck 2024.pdfwill854175
 
Falcon Invoice Discounting: Unlock Your Business Potential
Falcon Invoice Discounting: Unlock Your Business PotentialFalcon Invoice Discounting: Unlock Your Business Potential
Falcon Invoice Discounting: Unlock Your Business PotentialFalcon investment
 
Cannabis Legalization World Map: 2024 Updated
Cannabis Legalization World Map: 2024 UpdatedCannabis Legalization World Map: 2024 Updated
Cannabis Legalization World Map: 2024 UpdatedCannaBusinessPlans
 
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai KuwaitThe Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwaitdaisycvs
 
Challenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
Challenges and Opportunities: A Qualitative Study on Tax Compliance in PakistanChallenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
Challenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistanvineshkumarsajnani12
 
Berhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Berhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDINGBerhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Berhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDINGpr788182
 
Phases of Negotiation .pptx
 Phases of Negotiation .pptx Phases of Negotiation .pptx
Phases of Negotiation .pptxnandhinijagan9867
 
Unveiling Falcon Invoice Discounting: Leading the Way as India's Premier Bill...
Unveiling Falcon Invoice Discounting: Leading the Way as India's Premier Bill...Unveiling Falcon Invoice Discounting: Leading the Way as India's Premier Bill...
Unveiling Falcon Invoice Discounting: Leading the Way as India's Premier Bill...Falcon Invoice Discounting
 
Getting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAI
Getting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAIGetting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAI
Getting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAITim Wilson
 
Chennai Call Gril 80022//12248 Only For Sex And High Profile Best Gril Sex Av...
Chennai Call Gril 80022//12248 Only For Sex And High Profile Best Gril Sex Av...Chennai Call Gril 80022//12248 Only For Sex And High Profile Best Gril Sex Av...
Chennai Call Gril 80022//12248 Only For Sex And High Profile Best Gril Sex Av...pujan9679
 
QSM Chap 10 Service Culture in Tourism and Hospitality Industry.pptx
QSM Chap 10 Service Culture in Tourism and Hospitality Industry.pptxQSM Chap 10 Service Culture in Tourism and Hospitality Industry.pptx
QSM Chap 10 Service Culture in Tourism and Hospitality Industry.pptxDitasDelaCruz
 

Kürzlich hochgeladen (20)

Escorts in Nungambakkam Phone 8250092165 Enjoy 24/7 Escort Service Enjoy Your...
Escorts in Nungambakkam Phone 8250092165 Enjoy 24/7 Escort Service Enjoy Your...Escorts in Nungambakkam Phone 8250092165 Enjoy 24/7 Escort Service Enjoy Your...
Escorts in Nungambakkam Phone 8250092165 Enjoy 24/7 Escort Service Enjoy Your...
 
HomeRoots Pitch Deck | Investor Insights | April 2024
HomeRoots Pitch Deck | Investor Insights | April 2024HomeRoots Pitch Deck | Investor Insights | April 2024
HomeRoots Pitch Deck | Investor Insights | April 2024
 
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan CytotecJual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
 
UAE Bur Dubai Call Girls ☏ 0564401582 Call Girl in Bur Dubai
UAE Bur Dubai Call Girls ☏ 0564401582 Call Girl in Bur DubaiUAE Bur Dubai Call Girls ☏ 0564401582 Call Girl in Bur Dubai
UAE Bur Dubai Call Girls ☏ 0564401582 Call Girl in Bur Dubai
 
Lucknow Housewife Escorts by Sexy Bhabhi Service 8250092165
Lucknow Housewife Escorts  by Sexy Bhabhi Service 8250092165Lucknow Housewife Escorts  by Sexy Bhabhi Service 8250092165
Lucknow Housewife Escorts by Sexy Bhabhi Service 8250092165
 
PHX May 2024 Corporate Presentation Final
PHX May 2024 Corporate Presentation FinalPHX May 2024 Corporate Presentation Final
PHX May 2024 Corporate Presentation Final
 
Berhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Berhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDINGBerhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Berhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
 
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDINGParadip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
 
Arti Languages Pre Seed Teaser Deck 2024.pdf
Arti Languages Pre Seed Teaser Deck 2024.pdfArti Languages Pre Seed Teaser Deck 2024.pdf
Arti Languages Pre Seed Teaser Deck 2024.pdf
 
Falcon Invoice Discounting: Unlock Your Business Potential
Falcon Invoice Discounting: Unlock Your Business PotentialFalcon Invoice Discounting: Unlock Your Business Potential
Falcon Invoice Discounting: Unlock Your Business Potential
 
Cannabis Legalization World Map: 2024 Updated
Cannabis Legalization World Map: 2024 UpdatedCannabis Legalization World Map: 2024 Updated
Cannabis Legalization World Map: 2024 Updated
 
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai KuwaitThe Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
 
Challenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
Challenges and Opportunities: A Qualitative Study on Tax Compliance in PakistanChallenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
Challenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
 
Berhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Berhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDINGBerhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Berhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
 
Phases of Negotiation .pptx
 Phases of Negotiation .pptx Phases of Negotiation .pptx
Phases of Negotiation .pptx
 
Unveiling Falcon Invoice Discounting: Leading the Way as India's Premier Bill...
Unveiling Falcon Invoice Discounting: Leading the Way as India's Premier Bill...Unveiling Falcon Invoice Discounting: Leading the Way as India's Premier Bill...
Unveiling Falcon Invoice Discounting: Leading the Way as India's Premier Bill...
 
Getting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAI
Getting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAIGetting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAI
Getting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAI
 
Chennai Call Gril 80022//12248 Only For Sex And High Profile Best Gril Sex Av...
Chennai Call Gril 80022//12248 Only For Sex And High Profile Best Gril Sex Av...Chennai Call Gril 80022//12248 Only For Sex And High Profile Best Gril Sex Av...
Chennai Call Gril 80022//12248 Only For Sex And High Profile Best Gril Sex Av...
 
QSM Chap 10 Service Culture in Tourism and Hospitality Industry.pptx
QSM Chap 10 Service Culture in Tourism and Hospitality Industry.pptxQSM Chap 10 Service Culture in Tourism and Hospitality Industry.pptx
QSM Chap 10 Service Culture in Tourism and Hospitality Industry.pptx
 
WheelTug Short Pitch Deck 2024 | Byond Insights
WheelTug Short Pitch Deck 2024 | Byond InsightsWheelTug Short Pitch Deck 2024 | Byond Insights
WheelTug Short Pitch Deck 2024 | Byond Insights
 

How Can Europe Help to Speed Up Your Drug Development - Karl Peter Klein, AtoZ-CRO GmbH

  • 1. Presentation by Dr. med. Karl-Peter Klein Dip Pharm Med RCP UK, FFPM RCP UK Managing Director AtoZ-CRO GmbH Clinical Research Leyenhaus 29, 51491 Overath/Germany e-mail: kp.klein@atoz-cro.de www.atoz-cro.de Presented at the Marcus Evans Evolution Summit Conference Westin Chicago North Shore - Wheeling, IL, USA on May 1, 2012 2012‐05‐01 1
  • 2. How can Europe help to speed up your drug development Conditions, Rules and Cost of doing clinical trials in Central and Eastern Europe 2
  • 3.
  • 4. Content • Patients with rare diseases • Availability of motivated patients • Drug naive patients • Motivated investigators • Very experienced investigators • Quality of data • Fast Marketing Autorisation • Fast Marketing Success • Cost for clinical trials is lower in Europe • Conditions to start trials in Europe 4
  • 5. How can Europe help to speed up your drug development Rare Diseases Europe can help to speed up recruitment by having access to greater patient populations in rare diseases 5
  • 6. How can Europe help to speed up your drug development Availability of motivated patients Esp. in Eastern Europe for certain patients there is a lack of medical treatment; this causes a high motivation to enter clinical trials Patients travel long distances to meet the investigators Patients are highly motivated and show a high compliance 6
  • 7. How can Europe help to speed up your drug development Drug Naive Patients In some areas in Europe patients are not overloaded with other drugs as they are in the US or Germany, this means drug effects may be seen clearer and earlier, this is of incredible value and may speed up development process or allow earlier decisions 7
  • 8. How can Europe help to speed up your drug development Many motivated Investigators In Europe there are many highly motivated investigators and trial sites 8
  • 9. How can Europe help to speed up your drug development Very experienced Investigators In Europe there are many very experienced investigators and trial sites 9
  • 10. How can Europe help to speed up your drug development Quality of Data Most inspection results by the US FDA in Europe have shown a good quality of data Based on experience of inspectors from the US FDA, the number of findings in Europe are about the same as in the US 10
  • 11. How can Europe help to speed up your drug development The cost for clinical trials is lower in Europe compared to US In Western Europe cost is about 80% In Eastern Europe about 50% of the cost in the US 11
  • 12. How can Europe help to speed up your drug development Fast Marketing Autorisation Involvement of study sites in Europe in early drug development supports the later appoval process in Europe 12
  • 13. How can Europe help to speed up your drug development Fast Marketing Success Involvement of study sites in Europe in the drug development later on supports the marketing of these drugs 13
  • 14. Conditions, Rules of doing clinical trials in Europe Conditions to start trials in Europe • There is a certain hormonization in the EU countries • Offices in Europe or a legal representative • Qualified Person for PV within the EU • Approval of the Clinical Trial Application by the Competent Authority • Positive vote by the Ethics Committee (EC) 14
  • 15. Conditions, Rules of doing clinical trials in Europe CTA Review - Applicaton is validated - 30 (or 60) days review - Deficiency letter may be issued - After the response an additonal review is completed 15
  • 16. The ICH-GCP compliance, the availability of subjects, the quality of investigators, the time-reduced and the low costs are by far the important criteria for choosing Eastern Europe countries to conduct clinical trials. 16
  • 17. Conclusion Conducting trials in Europe may help to - accelerate development - reduce costs - support international registration - support international marketing 17
  • 18. Thank you 18